Michael Paul Andre

Dr. Michael Paul Andre

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2020 in Radiology
Verified
Journal Article
Closed access
AHAiguo Han
Aiguo Han
MBMichal Byra
Michal Byra
EHElhamy Heba
Elhamy Heba
MAMichael Paul Andre
Michael Paul Andre
JEJohn Erdman
John Erdman
WOWilliam D. O’brien
William D. O’brien
When other causes of steatosis are excluded, de novo one-dimensional convolutional neural network algorithms can accurately identify nonalcoholic fatty liver disease and quantify hepatic fat fracti... Background Radiofrequency ultrasound data from the liver contain rich information about liver microstructure and composition. Deep learning might exploit such information to assess nonalcoholic fat...

4 February 2020 in Radiology
Verified
Journal Article
Closed access
AHAiguo Han
Aiguo Han
YZYingzhen N. Zhang
Yingzhen N. Zhang
ABAndrew S. Boehringer
Andrew S. Boehringer
VMVivian Montes
Vivian Montes
MAMichael Paul Andre
Michael Paul Andre
WOWilliam D. O’bRien
William D. O’bRien
A multivariable quantitative US approach showed feasibility as an accurate method for hepatic steatosis assessment in nonalcoholic fatty liver disease compared with MRI proton density fat fraction. Background Advanced confounder-corrected chemical shift–encoded MRI-derived proton density fat fraction (PDFF) is a leading parameter for fat fraction quantification in nonalcoholic fatty liver dis...

15 May 2023 in Sensors
Verified
Journal Article
Open access
PDF file
AAAria Ashir
Aria Ashir
SJSAEED JERBAN
SAEED JERBAN
VBVictor Barrère
Victor Barrère
YWYuanshan Wu
Yuanshan Wu
SSSameer B. Shah
Sameer B. Shah
ECEric Chang
Eric Chang
Ultrasound (US) is an important imaging tool for skeletal muscle analysis. The advantages of US include point-of-care access, real-time imaging, cost-effectiveness, and absence of ionizing radiation. However, US can be highly dependent on the operator and/or US system, and a portion of the potentially useful information carried by raw sonographic data is discarded in image formation for routine qualitative US. Quantitative ultrasound (QUS) methods provide analysis of the raw or post-processed data, revealing additional information about normal tissue structure and disease status. There are four QUS categories that can be used on muscle and are important to review. First, quantitative data derived from B-mode images can help determine the macrostructural anatomy and microstructural morphology of muscle tissues. Second, US elastography can provide information about muscle elasticity or stiffness through strain elastography or shear wave elastography (SWE). Strain elastography measures the induced tissue strain caused either by internal or external compression by tracking tissue displacement with detectable speckle in B-mode images of the examined tissue. SWE measures the speed of induced shear waves traveling through the tissue to estimate the tissue elasticity. These shear waves may be produced using external mechanical vibrations or internal “push pulse” ultrasound stimuli. Third, raw radiofrequency signal analyses provide estimates of fundamental tissue parameters, such as the speed of sound, attenuation coefficient, and backscatter coefficient, which correspond to information about muscle tissue microstructure and composition. Lastly, envelope statistical analyses apply various probability distributions to estimate the number density of scatterers and quantify coherent to incoherent signals, thus providing information about microstructural properties of muscle tissue. This review will examine these QUS techniques, published results on QUS evaluation of skeletal muscles, and the strengths and limitations of QUS in skeletal muscle analysis.

13 December 2023 in IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control
Verified
Journal Article
Open access
PSPengfei Song
Pengfei Song
MAMichael Paul Andre
Michael Paul Andre
Parag V ChitnisParag V Chitnis
Parag V Chitnis
Sheng XuSheng Xu
Sheng Xu
TCTheodore Croy
Theodore Croy
SSSiddhartha Sikdar
Siddhartha Sikdar
Wearable ultrasound has the potential to become a disruptive technology enabling new applications not only in traditional clinical settings, but also in settings where ultrasound is not currently used. Understanding the basic engineering principles and limitations of wearable ultrasound is critical for clinicians, scientists, and engineers to advance potential applications and translate the technology from bench to bedside. Wearable ultrasound devices, especially monitoring devices, have the potential to apply acoustic energy to the body for far longer durations than conventional diagnostic ultrasound systems. Thus, bioeffects associated with prolonged acoustic exposure as well as skin health need to be carefully considered for wearable ultrasound devices. This article reviews emerging clinical applications, safety considerations, and future engineering and clinical research directions for wearable ultrasound technology.

23 January 2018 in Journal of Ultrasound in Medicine
Verified
Journal Article
Open access
PDF file
AHAiguo Han
Aiguo Han
MAMichael Paul Andre
Michael Paul Andre
LDLisa Deiranieh
Lisa Deiranieh
EHElise Housman
Elise Housman
JEJohn Erdman
John Erdman
WOWilliam D. O'Brien
William D. O'Brien
Objectives: To assess the repeatability and reproducibility of the ultrasonic attenuation coefficient (AC) and backscatter coefficient (BSC) measured in the livers of adults with known or suspected nonalcoholic fatty liver disease (NAFLD).Methods: The Institutional Review Board approved this Health Insurance Portability and Accountability Act–compliant prospective study; informed consent was obtained. Forty‐one research participants with known or suspected NAFLD were recruited and underwent same‐day ultrasound examinations of the right liver lobe with a clinical scanner by a clinical sonographer. Each participant underwent 2 scanning trials, with participant repositioning between trials. Two transducers were used in each trial. For each transducer, machine settings were optimized by the sonographer but then kept constant while 3 data acquisitions were obtained from the liver without participant repositioning and then from an external calibrated phantom. Raw RF echo data were recorded. The AC and BSC were measured within 2.6 to 3.0 MHz from a user‐defined hepatic field of interest from each acquisition. The repeatability and reproducibility were analyzed by random‐effects models.Results: The mean AC and log‐transformed BSC (logBSC) were 0.94 dB/cm‐MHz and –27.0 dB, respectively. Intraclass correlation coefficients were 0.88 to 0.94 for the AC and 0.87 to 0.95 for the logBSC acquired without participant repositioning. For between‐trial repeated scans with participant repositioning, the intraclass correlation coefficients were 0.80 to 0.84 for the AC and 0.69 to 0.82 for the logBSC after averaging results from 3 within‐trial images. The variability introduced by the transducer was less than the repeatability error.Conclusions: Hepatic AC and BSC measures using a reference phantom technique on a clinical scanner are repeatable and reproducible between transducers in adults with known or suspected NAFLD.

10 March 2021 in Journal of Ultrasound in Medicine
Verified
Journal Article
Closed access
PDF file
MBMichal Byra
Michal Byra
AHAiguo Han
Aiguo Han
ABAndrew S. Boehringer Bs
Andrew S. Boehringer Bs
YZYingzhen N. Zhang
Yingzhen N. Zhang
WOWilliam D. O'BRien
William D. O'BRien
MAMichael Paul Andre
Michael Paul Andre